BNP Paribas Exane analyst Nate Crossett upgraded W.P. Carey (WPC) to Neutral from Underperform with a $66 price target The firm left meetings with management “incrementally more positive” on the shares. W.P. Carey’s acquisition pipeline “seems promising” and its portfolio quality has improved after the resolution of issues with Do it Best and Hearthside, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WPC:
- W.P. Carey upgraded to Neutral from Underperform at BNP Paribas Exane
- W.P. Carey price target raised to $61 from $60 at Barclays
- W.P. Carey price target lowered to $63 from $66 at UBS
- W.P. Carey price target raised to $64 from $63 at Scotiabank
- W.P. Carey price target raised to $66 from $62 at RBC Capital